HomeCTNM • NASDAQ
add
Contineum Therapeutics Inc
Previous close
$4.01
Day range
$3.97 - $4.35
Year range
$3.35 - $21.92
Market cap
106.33M USD
Avg Volume
141.89K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 18.11M | 82.38% |
Net income | -15.99M | -89.97% |
Net profit margin | — | — |
Earnings per share | -0.62 | 82.54% |
EBITDA | -18.03M | -82.71% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 190.71M | 61.75% |
Total assets | 198.26M | 60.45% |
Total liabilities | 13.50M | 105.32% |
Total equity | 184.77M | — |
Shares outstanding | 25.87M | — |
Price to book | 0.56 | — |
Return on assets | -22.03% | — |
Return on capital | -22.92% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -15.99M | -89.97% |
Cash from operations | -14.41M | -80.71% |
Cash from investing | 14.92M | 70.83% |
Cash from financing | 24.00K | 233.33% |
Net change in cash | 527.00K | -28.59% |
Free cash flow | -9.54M | -134.34% |
About
Founded
2009
Website
Employees
41
